You are the profession. Have your say.™
VetCell becomes UK's first authorised equine stem cell centre
VetCell Bioscience has become the first UK-based stem cell centre to be authorised under the Veterinary Medicines Regulations.
Stem cell therapy involves implanting millions of the animal's own stem cells and autologous growth factors directly into the injured tendon or ligament. The service VetCell Bioscience offers is the collection, storage, processing and supply of stem cells suitable for administration back into the donor animal.
New regulations for the provision of autologous stem cells were introduced by the Veterinary Medicines Directorate (VMD) towards the end of 2008, to ensure that the highest standards are continually maintained for all animal stem cell products in the UK.
Following a rigorous series of inspections and reports by Good Manufacturing Practice (GMP) Inspectors, VetCell - in conjunction with its UK laboratory partner, Biobest - was officially authorised as an equine stem cell centre on 1 October 2009.
David Mountford, chief operating officer of VetCell Bioscience, said: "To have received formal authorisation so swiftly reflects the high standard of our operation and our ability to lead the field in the increasingly competitive sector of stem cell technology."
According to VetCell, there is considerable interest from the human sector; and studies in human medicine for the treatment of Achilles tendinopathies, could begin as early as next year.
For further information, e-mail vets@vetcell.com or telephone + 44(0)1223 493488.
Published: 01 Nov 2009
0 Comments
Tags: Company News, Equine, News
Commenting is now closed.